Acute Migraine Treatment Market

Acute Migraine Treatment Market is projected to grow from USD 2.95 Billion in 2025 to USD 4.58 Billion by 2036, at a CAGR of 4.5%. In terms of drug, Triptans is expected to hold the largest share at 31.2%, while Hospitals Pharmacies will account for a 36.2% share in the distribution channel segment.